RMD · 8-K · 20260806PR337962
Acquisitions and Divestitures
RESMED INC · 2026-08-06 · Importance 71 · Surprise 60 · In source text
ResMed announced an agreement to sell its MatrixCare business, with closing expected during the first quarter of fiscal 2027. The balance sheet classified $457.4 million of assets and $41.2 million of liabilities as held for sale at June 30, 2026. ResMed also completed its acquisition of Noctrix Health, a medical-device company selling FDA De Novo classified wearable therapeutics for Restless Leg Syndrome.
Key facts
- Completed acquisition of Noctrix Health, a medical device company selling FDA De Novo classified wearable therapeutics for Restless Leg Syndrome source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| assets | positive | realized | — | Completed acquisition of Noctrix Health, a medical device company selling FDA De Novo classified wearable therapeutics for Restless Leg… |
| revenue | positive | realized | — | Completed acquisition of Noctrix Health, a medical device company selling FDA De Novo classified wearable therapeutics for Restless Leg… |